Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Fate: Potentiating stem cells

Fate Therapeutics is taking a pharmaceutical approach to the biology of stem cells. The company initially will focus on developing small molecules and proteins that can prod adult stem cells in vivo to differentiate into cells that can then repair damaged tissues and cells. By doing so, Fate hopes to bypass problems with cell therapies, which have included manufacturing consistency and the difficulty in creating

Read the full 651 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers